Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Christian Behrenbruch Insider Profile

4 Followers

Christian Behrenbruch, Managing Director & Chief Executive Officer at Telix Pharmaceuticals, holds 21.44M shares in Telix Pharmaceuticals (Ticker: TLPPF), holds 2.74M shares in Amplia Therapeutics (Ticker: INNMF), holds 3.27M shares in Dominion Minerals Limited (Ticker: DE:1TT). Most recently, Christian Behrenbruch Bought ― shares of Telix Pharmaceuticals on Oct 27, 2026 for an estimated value of $499.62K.

Christian Behrenbruch's Trading History

TLPPFTelix Pharmaceuticals		Oct 27, 2026Managing Director & Chief Executive OfficerInformative Buy499.62K$191.85M
INNMFAmplia Therapeutics		Sep 17, 2019DirectorInformative Buy25.00K$148.08K
1TTDominion Minerals Limited		Apr 24, 2018ExecutiveInformative Buy16.33K€52.24K
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Christian Behrenbruch insider profile FAQ

What is the percentage of profitable transactions made by Christian Behrenbruch?
The percentage of profitable transactions made by Christian Behrenbruch is 67%.
What is the average return per transaction made by Christian Behrenbruch?
The average return per transaction made by Christian Behrenbruch is 44.80%.
What stocks does Christian Behrenbruch hold?
Christian Behrenbruch holds: TLPPF, INNMF, DE:1TT stocks.
What was Christian Behrenbruch’s latest transaction?
Christian Behrenbruch’s latest transaction was an Informative Buy of $499.62K.
What was Christian Behrenbruch's most profitable transaction?
Christian Behrenbruch’s most profitable transaction was an Informative Buy of INNMF stock on September 17, 2019. The return on the trade was 133.30%.
What is Christian Behrenbruch's role in Telix Pharmaceuticals?
Christian Behrenbruch's role in Telix Pharmaceuticals is Managing Director & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.